期刊文献+

抗肿瘤药物研究进展 被引量:5

Developments of anti-tumor drug research
下载PDF
导出
摘要 综述和分析了抗肿瘤药物近年来的新进细胞毒性抗肿瘤药物、以细胞信号转导分子的抗肿瘤药物、新生血管生成抑制剂、肿瘤耐剂、内分泌治疗药等。 Recent developments and approaches for anti-tumor drugs were reviewed and analysed in this manuscript, including new agents of traditional cytotoxity, protein tyrosine kinase inhibitors, farnesyltransferase inhibitors, tumor angiogenesis inhibitors, resistance reversal agents, endocrinal therapy and so forth.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第2期139-143,共5页 Chinese Journal of New Drugs and Clinical Remedies
关键词 抗肿瘤药 蛋白质酪氨酸激酶 血管生成抑制剂 芳香酶抑制剂 法尼基转移酶 antineoplastic agents protein-tyrosine kinase angiogenesis inhibitors aromatase inhibitors farnesyltransferase
  • 相关文献

参考文献20

  • 1[1]GELDERBLOM H,SALAZAR R,VERWEIJ J,et al.Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915),a novel E-ring-modified camptothecin analogue in adults with solid tumors [J].Clin Cancer Res,2003,9(11):4101-4107. 被引量:1
  • 2[2]HANNA N,SHEPHERD FA,FOSSELLA FV,et al.Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy[J].J Clin Oncol,2004,22(9):1589-1597. 被引量:1
  • 3[3]KELLAND LR.An update on satraplatin:the first orally available platinum anticancer drug[J].Expert Opin Investig Drug,2000,9(6):1373-1382. 被引量:1
  • 4[4]DUFFAUD F,BLAY JY.Gastrointestinal stromal tumors:biology and treatment[J].Oncology,2003,65(3):187-197. 被引量:1
  • 5[5]GIACCONE G,HERBST RS,MANEGOLD C,et al.Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:a phase III trial--INTACT 1[J].J Clin Oncol,2004,22(5):777-784. 被引量:1
  • 6[6]VENET M,END M,ANGIBAUD P.Farnesyl protein transferase inhibitor ZARNESTRA R115777 - history of a discovery[J].Curr Top Med Chem,2003,3(10):1095-1102. 被引量:1
  • 7[7]van CUTSEM E,van de VELDE H,KARASEK P,et al.Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer[J].J Clin Oncol,2004,22(8):1430-1438. 被引量:1
  • 8[8]WANG EJ,JOHNSON WW.The farnesyl protein transferase inhibitor lonafarnib (SCH66336) is an inhibitor of multidrug resistance proteins 1 and 2[J].Chemotherapy,2003,49(6):303-308. 被引量:1
  • 9[9]TOPPMEYER DL,GOUNDER M,MUCH J,et al.A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy[J].Med Sci Monit,2003,9(8):PI 99- PI 104. 被引量:1
  • 10[10]HERBST RS.Targeted therapy using novel agents in the treatment of non-small-cell lung cancer[J].Clin Lung Cancer,2002,3 Supp1:S30-S38. 被引量:1

同被引文献74

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部